Tess Burleson

Insider Reports History

Entity
Individual
Location
2450 Holcome Blvd., Suite J 608, Houston, TX
Signature
/s/Mark Rosenblum, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tess Burleson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Salarius Pharmaceuticals, Inc. Director Stock Option (right to buy) 20.5K Feb 20, 2024 Direct

Insider Reports Filed by Tess Burleson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLRX Salarius Pharmaceuticals, Inc. Feb 20, 2024 1 $0 4 Feb 22, 2024 Director
SLRX Salarius Pharmaceuticals, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
SLRX Salarius Pharmaceuticals, Inc. Jun 7, 2022 1 $4.99K 4 Jun 8, 2022 Director
SLRX Salarius Pharmaceuticals, Inc. Jan 20, 2022 1 $0 4 Jan 21, 2022 Director